Multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distress
Latest Information Update: 20 Jul 2023
At a glance
- Drugs Poractant alfa (Primary) ; Poractant alfa (Primary)
- Indications Neonatal respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms SurfON
- 18 Jul 2023 Recruitment completion is expected on 28/02/2025, according to ISRCTN: Current Controlled Trials.
- 18 Jul 2023 Status changed to recruiting.
- 18 Jul 2023 Planned End Date changed from 30 Nov 2022 to 31 Aug 2025.